candida orthopsilosis
Geographic Distribution and Antifungal Susceptibility of the Newly Described Species Candida orthopsilosis and Candida metapsilosis in Comparison to the Closely Related Species Candida parapsilosis
... Candida orthopsilosis and Candida metapsilosis are recently described species, having previously been grouped with the more prevalent species Candida ...C. orthopsilosis and 34 ...C. ...
6
Genotyping of Candida orthopsilosis Clinical Isolates by Amplification Fragment Length Polymorphism Reveals Genetic Diversity among Independent Isolates and Strain Maintenance within Patients
... (Candida orthopsilosis and Candida metapsilosis) on the basis of extensive genomic differences and molecular phylogenetic analysis ...C. orthopsilosis and ...C. orthopsilosis and ...
8
Complete DNA sequences of the mitochondrial genomes of the pathogenic yeasts Candida orthopsilosis and Candida metapsilosis: Insight into the evolution of linear DNA genomes from mitochondrial telomere mutants
... With the aim of understanding how a mitochondrial genome with such a unique molecular architecture emerged in evolution we studied two yeasts, Candida orthopsilosis and Candida metapsilosis, closely ...
10
Candida orthopsilosis and Candida metapsilosis spp nov To Replace Candida parapsilosis Groups II and III
... Two new species, Candida orthopsilosis and C. metapsilosis, are proposed to replace the existing designations of C. parapsilosis groups II and III, respectively. The species C. parapsilosis is retained for ...
9
Caspofungin-Non-Susceptible Candida orthopsilosis Isolated from Onychomycosis in Iran
... of Candida, the antifungal susceptibility patterns of these clinically important organisms may have an application in clinical and epidemiological setting and deserve the implementation of local surveillance ...
7
Isolation of Lodderomyces elongisporus from the Catheter Tip of a Fungemia Patient in the Middle East
... The ascomycetous yeast Lodderomyces elongisporus has long been considered as a teleomorph of C. parapsilosis due to various phenotypic similarities that it shares with Candida parapsilosis. Early molecular studies ...
6
Identification of Medically Important Candida and Non Candida Yeast Species by an Oligonucleotide Array
... (Candida orthopsilosis and Candida metapsilosis) to replace Candida parapsilosis genotypes II and III, respectively, and the species Candida parapsilosis is retained for genotype I ...
10
Identification of Pathogenic Rare Yeast Species in Clinical Samples: Comparison between Phenotypical and Molecular Methods
... Although Candida and Aspergillus species are the most com- mon causes of invasive fungal infection (IFI) in debilitated individuals, almost all yeasts are potential pathogens, causing great morbidity and mortality ...
5
High Throughput Identification of Clinical Pathogenic Fungi by Hybridization to an Oligonucleotide Microarray
... Identification of isolated fungal pathogens from clinical samples. Eighty-six fungal pathogens isolated from clinical samples were processed and hybridized as described above and were then identified according to their ...
7
Use of Micafungin as a Surrogate Marker To Predict Susceptibility and Resistance to Caspofungin among 3,764 Clinical Isolates of Candida by Use of CLSI Methods and Interpretive Criteria
... of Candida (9), the European Committee on Antimicrobial Suscep- tibility Testing (EUCAST) has elected to establish CBPs for anidu- lafungin and micafungin but not for caspofungin ...
7
Practical Method for Detection and Identification of Candida, Aspergillus, and Scedosporium spp by Use of Rolling Circle Amplification
... DNA sequences spanning the ITS2 region of all major Can- dida, Aspergillus, and Scedosporium species were accessed from the GenBank database and compared using the Clustal W program (BioManager, ANGIS; ...
5
IN VITRO ANTIFUNGAL SUSCEPTIBILITY REVEALS OCCURRENCE OF AZOLE AND ALLYLAMINE RESISTANCE AMONG CLINICAL ISOLATES OF CANDIDA ALBICANS AND CANDIDA NON ALBICANS FROM CENTRAL INDIA
... DISCUSSION: This is a systematic study on antifungal susceptibility testing of C. albicans and non albicans clinical isolates, from Central state of India causing superficial and systemic Mycosis. All the isolates ...
9
Microevolution of Candida albicans Isolate from a Patient with Mucocutaneous Candidiasis and HIV Infection
... were digested with Msp1 enzyme to achieve length patterns. Restriction frag- ments were analysed by 2% agarose gel electrophoresis in TAE buffer; gels were stained with ethidium bromide and then photographed. C. albicans ...
9
Outbreak of candidemia caused by fluconazole resistant Candida parapsilosis strains in an intensive care unit
... It is well established that C. parapsilosis is a com- mensal of human skin that can be transmitted horizon- tally via contaminated external sources and hands of health care workers [36]. We tried to identify risk factors ...
6
Global Surveillance of In Vitro Activity of Micafungin against Candida: a Comparison with Caspofungin by CLSI Recommended Methods
... and Candida using these optimized ...2,000 Candida bloodstream infection (BSI) isolates determined by BMD using RPMI 1640 and a prom- inent inhibition (MIC-2) ...
6
CANDIDIASIS AMONG PREGNANT WOMEN: A REVIEW
... of Candida species among pregnant women. Of these, Candida albicans was the major isolate ...by Candida glabrata 6.3%; Candida parapsilosis 1.1% and Candida kefyr ...reported ...
9
Fluconazole and Voriconazole Multidisk Testing ofCandida Species for Disk Test Calibration and MIC Estimation
... with Candida species are common complications in immunocompromised patients and require adequate treat- ment, often with newer azole ...among Candida species and for calibration of the disk ...
7
In Vitro Activities of Isavuconazole and Comparator Antifungal Agents Tested against a Global Collection of Opportunistic Yeasts and Molds
... of Candida and Aspergillus. Furthermore, the isolates of Candida for which the echinocandin MIC values exceeded the thresholds defined by the CBPs or ECVs possessed resistance mu- tations in hot spot ...
9
THE ANTIMICROBIAL ACTIVITY OF HONEY AND PROPOLIS AGAINST YEASTS CANDIDA SPECIES
... yeasts: Candida crusei, Candida albicans, Candida (Torulopsis) glabrata, Candida parapsilosis and Candida ...that Candida crusei was the most sensitive in 70 % of EEP, and the ...
7
Validation of a simplex PCR assay enabling reliable identification of clinically relevant Candida species
... PCR efficiency and the limit of reliable detection (LoRD) Amplification reactions were carried out on three differ- ent PCR platforms; P1, P2, P3. Duplicate PCRs were per- formed at every dilution of the Candida ...
13